Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
News Menu

News

Medical News

Wed, Apr 24th, 2019
Forge And Basilea Enter Into Multi-Target Agreement To Discover And Develop Novel Antibiotics

SAN DIEGO , April 24, 2019 /PRNewswire/ -- Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd. [SIX: BSLN],...

Resolutions at the Annual General Meeting in Biotage AB on April 24, 2019

STOCKHOLM , April 24, 2019 /PRNewswire/ -- At the Annual General Meeting held in Biotage AB (Reg. No. 556539-3138) on April 24, 2019 , the following resolutions were passed, among others.

UN: No screen time for babies; only 1 hour for kids under 5

LONDON (AP) — The World Health Organization has issued its first-ever guidance for how much screen time children under 5 should get: not very much, and none at all for those under 1.

Interim Report January - March 2019

UPPSALA, Sweden , April 24, 2019 /PRNewswire/ -- First quarter January - March 2019

BITGF : 14.4000 (+24.65%)
Small Business Health Insurance Offers a Better Deal for Many than Individual Coverage, According to eHealth Report

SANTA CLARA, Calif. , April 24, 2019 /PRNewswire/ -- Today eHealth, Inc. (NASDAQ: EHTH) ( eHealth.com ) released a report  on 2018 small business health insurance costs and trends among...

EHTH : 60.97 (+1.36%)
TerrAscend Announces Fourth Quarter 2018 Financial Results

Company reiterates previously issued guidance anticipating 2019 full year revenue exceeding $135 million. 1   

TER : 48.64 (+9.08%)
TRSSF : 6.0700 (-1.62%)
MDxHealth provides Q1 2019 business update

IRVINE, Calif. , and HERSTAL, Belgium , April 24, 2019 /PRNewswire/ -- MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today provided a business...

GT Biopharma (GTBP) Announces the Elimination of HIV Infected Cells Using its Tri-Specific Killer Engagers (TriKEs) in Preclinical Testing at the University of Minnesota

TAMPA, Florida , April 24, 2019 /PRNewswire/ -- GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology biotechnology company focused on innovative treatments based on the Company's proprietary...

GTBP : 0.4700 (+46.88%)
Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System

SUNNYVALE, Calif. , April 24, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the launch of its Synchrony ® motion tracking and correction technology 1  to be...

ARAY : 4.27 (-3.39%)
CytoSorbents Highlights the 6th International CytoSorb Users' Meeting and Recent Activities at the 2019 ISICEM and EuroELSO Conferences

MONMOUTH JUNCTION, N.J. and BERLIN , April 24, 2019 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood...

CNA : 44.35 (-0.07%)
CTSO : 7.05 (-0.28%)
Provention Bio Completes Enrollment of Phase 2a PRINCE Clinical Trial with PRV-6527 in Patients with Moderate to Severe Crohn's Disease

OLDWICK, N.J. , April 24, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases,...

PRVB : 3.39 (+1.19%)
Thermo Fisher Scientific Reports First Quarter 2019 Results

WALTHAM, Mass. , April 24, 2019 /PRNewswire/ --  Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended...

TMO : 263.87 (-0.02%)
United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , April 24, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2019...

UTHR : 103.56 (-0.72%)
Rainbow Light and Vitamin Angels Celebrate 25 years of Helping Women and Children in Need with Vitamin Drops in 25 U.S. Communities

SUNRISE, Fla. , April 24, 2019 /PRNewswire/ -- Rainbow Light® ( www.rainbowlight.com ), a leading developer of vitamins and supplements, today announced that it will be honoring 25 years of...

CLX : 153.89 (+0.23%)
BerGenBio ASA: Invitation to First Quarter Presentation and Webcast

BERGEN, Norway , April 24, 2019 /PRNewswire/ -- BerGenBio ASA (OSE:BGBIO), will announce its results for the first quarter on Wednesday, 8 May 2019 . A presentation by BerGenBio's senior management...

Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

SEATTLE and VANCOUVER, British Columbia , April 24, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...

ACHV : 4.23 (+4.44%)
Immunovia Interim Report, January-March 2019

STOCKHOLM , April 24, 2019 /PRNewswire/ -- During the first quarter of 2019, we remained focused on our product launch strategy and continued to create value, as we reached several key objectives...

IRRAS Provides Update on CE Mark Re-Certification of IRRAflow®

STOCKHOLM , April 24, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical technology company focused on developing and commercializing innovative solutions...

Oncopeptides Provides New Guidance on the Patient Recruitment in the OCEAN Study and a Clinical Program Update in a Webcast at 10:00 (CET)

STOCKHOLM , April 24, 2019 /PRNewswire/ --  Oncopeptides AB (Nasdaq Stockholm: ONCO) announces today that the company will provide an update on patient recruitment in the ongoing phase 3 study...

AbbVie Expands Immunology Portfolio in the U.S. with FDA Approval of SKYRIZI™ (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

NORTH CHICAGO, Ill. , April 23, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved...

ABBV : 78.86 (+0.25%)

Chart of the Day

Federal Signal Corp (FSS)

The Barchart Chart of the Day belongs to the diversified company Federal Signal (FSS). I found the stock by sorting Barchart's Top Stocks to Own list first by the most frequent number of new highs in the last month, then I used the Flipchart fea...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar